SymBio Pharmaceuticals Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SymBio Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 56 JPY Market Closed

Market Cap: ¥4.5B

S	SymBio Pharmaceuticals Ltd TSE:4582	JP
C	CJ Freshway Corp KOSDAQ:051500	KR
A	Atea ASA SWB:MKL	NO
	Snam SpA OTC:SNMRF	IT
	Tesla Inc NASDAQ:TSLA	US
A	Asahi Kasei Corp SWB:ASAA	JP
H	Hartford Insurance Group Inc LSE:0J3H	US
	Cooper-Standard Holdings Inc NYSE:CPS	US
C	Cemex SAB de CV F:CEXA	MX
	Maple Gold Mines Ltd XTSX:MGM	CA
C	CA Sales Holdings Ltd JSE:CAA	ZA

Profitability Summary

SymBio Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

76%

Declining Gross Margin

79% > 70%

Negative Operating Margin

-524%

Negative 3Y Average Operating Margin

-201%

Declining Operating Margin

1% > -524%

Negative Net Margin

-533%

Negative 3Y Average Net Margin

-217%

Declining Net Margin

-16% > -533%

Negative Free Cash Flow Margin

-409%

Negative 3Y Average Free Cash Flow Margin

-176%

Declining Free Cash Flow Margin

3% > -409%

Negative ROE

-677%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-314%

Declining ROIC

-122% > -591%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.